Greg Weaver
CFO @ Altimmune
Cambridge, United States
Greg Weaver is a startup investor at Altimmune in Cambridge. Greg Weaver is the current Chief Financial Officer of Altimmune. He previously worked at Cognito Therapeutics as a Chief Financial Officer. Greg Weaver attended Boston College.
Last updated:
For AI agents: llms.txt
About Altimmune
Altimmune is an emerging biotechnology company located in Montgomery County, MD. Altimmune develops vaccines and other biological products to address unmet market and public health needs. The company uses a proprietary technology for non-invasive intranasal delivery, and has shown proof of principle in animals and in initial human clinical studies.Vaxin Inc., formerly known as Vaxin Pharmaceuticals and ImmuneFocus Corporation, was founded in 1997 by Emerging Technology Partners. Early experiments revealed that DNA incorporated into an adenovirus can elicit an immune response when placed on the surface of the skin, and subsequently research was expanded to include applications on the skin in the nose as well as experimentation with other vectors.
Altimmune Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Greg Weaver
CFO
|
|||
|
Bertrand Georges
Chief Technology Officer
|
|||
|
Joe Theis
Outside General Counsel
|
|||
M. Scot Roberts
Chief Scientific Officer
|
|||
M Scott Harris
Chief Medical Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
